Clinical Trial Update: Evaluate the Safety and Efficacy of CAR-T Cells in the Treatment of R/R Neuromyelitis Optica [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating the safety and efficacy of CAR-T cell therapy for relapsed/refractory Neuromyelitis Optica has completed. The sponsor is Zheji…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuromyelitis Optica

Drugs mentioned

• CAR-T cell therapy

Snippet

Sponsor: Zhejiang University | Conditions: Neuromyelitis Optica | Phase 1 | Status: COMPLETED